Howard Greene, co-founder of Amylin Pharmaceuticals, joined the company's ongoing proxy fight in a letter urging shareholders to vote for a slate of directors being pushed by dissident investor groups led by billionaire Carl Icahn and Eastbourne Capital Management...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99